Phenotypic variability within the inclusion body spectrum of basophilic inclusion body disease and neuronal intermediate filament inclusion disease in frontotemporal lobar degenerations with fus-positive inclusions

Journal of Neuropathology and Experimental Neurology

Volumn 71, Issue 9, 2012, Pages 795-805

  Gelpi, Ellen ^a   Lladó, Albert ^b   Clarimón, Jordi ^c,d   Rey, Maria Jesús ^a   Rivera, Rosa Maria ^a   Ezquerra, Mario ^b   Antonell, Anna ^b   Navarro Otano, Judith ^a,b   Ribalta, Teresa ^a   Piñol Ripoll, Gerard ^e   Pérez, Anna ^f   Valldeoriola, Francesc ^b   Ferrer, Isidre ^g  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^e Neurology Service   (Spain)

^f Hospital Santa Maria de Lleida   (Spain)

^g HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Internexin; Basophilic inclusion body disease; Frontotemporal lobar degeneration; FUS; Hyaline conglomerates; Immunohistochemistry; Neuronal intermediate filament inclusion disease

Indexed keywords

ALPHA INTERNEXIN; FUSED IN SARCOMA PROTEIN;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; AUTOPSY; BASOPHILIC INCLUSION BODY DISEASE; BRAIN DISEASE; CASE REPORT; CELL INCLUSION; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE COURSE; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GENETIC SCREENING; HUMAN; MALE; MENTAL DISEASE; NEURONAL INTERMEDIATE FILAMENT INCLUSION DISEASE; NEUROPATHOLOGY; PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; RARE DISEASE;

ADULT; AGED; BASOPHILS; DNA MUTATIONAL ANALYSIS; FEMALE; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; INCLUSION BODIES; INTERMEDIATE FILAMENTS; MALE; MIDDLE AGED; NEURONS; PHENOTYPE; POSTMORTEM CHANGES; RNA-BINDING PROTEIN FUS;

EID: 84865660724     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e318266efb1     Document Type: Article

References (25)

1. Mackenzie IR, Neumann M, Bigio EH, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: An update. Acta Neuropathol 2010;119:1-4
2. Cairns NJ, Bigio EH, Mackenzie IR, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: Consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuro-pathol 2007;114:5-22
3. Cairns NJ, Grossman M, Arnold SE, et al. Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology 2004;63:1376-84
4. Josephs KA, Holton JL, Rossor MN, et al. Neurofilament inclusion body disease: A new proteinopathy? Brain 2003;126:2291-303
5. Josephs KA, Uchikado H, McComb RD, et al. Extending the clin-icopathological spectrum of neurfilament inclusion disease. Acta Neu-ropathol 2005;109:427-32
6. Molina-Porcel L, Lladó A, Rey MJ, et al. Clinical and pathological heterogeneity of neuronal intermediate filament inclusion disease. Arch Neurol 2008;65:202-5
7. Ishihara K, Araki S, Ihori N, et al. An autopsy case of frontotemporal dementia with severe dysarthria and motor neuron disease showing numerous basophilic inclusions. Neuropathology 2006;26:447-54
8. Mackenzie IR, Munoz DG, Kusaka H, et al. Distinct pathological subtypes of FTLD-FUS. Acta Neuropathol 2011;121:207-18
9. Munoz DG, Neumann M, Kusaka H, et al. FUS pathology in basophilic inclusion body disease. Acta Neuropathol 2009;118:617-27
10. Neumann M, Roeber S, Kretzschmar HA, et al. Abundant FUS-immu-noreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathol 2009;118:605-16
11. Doi H, Koyano S, Suzuki Y, et al. The RNA-binding protein FUS/TLS is a common aggregate-interacting protein in polyglutamine diseases. Neurosci Res 2010;66:131-33
12. Kusaka H, Matsumoto S, Imai T. An adult-onset case of sporadic motor neuron disease with basophilic inclusions. Acta Neuropathol 1990;80: 660-65
13. Kusaka H, Matsumoto S, Imai T. Adult-onset motor neuron disease with basophilic intraneuronal inclusion bodies. Clin Neuropathol 1993; 12:215-18
14. Matsumoto S, Kusaka H, Murakami N, et al. Basophilic inclusions in sporadic juvenile amyotrophic lateral sclerosis: An immunocytochemical and ultrastructural study. Acta Neuropathol 1992;83:579-83
15. Aizawa H, Kimura T, Hashimoto K, et al. Basophilic cytoplasmic inclusions in a case of sporadic juvenile amyotrophic lateral sclerosis. J Neurol Sci 2000;176:109-13
16. Sasaki S, Toi S, Shirata A, et al. Immunohistochemical and ultrastructural study of basophilic inclusions in adult-onset motor neuron disease. Acta Neuropathol 2001;102:200-6
17. Bigio EH, Lipton AM, White CL 3rd, et al. Frontotemporal and motor neuron degeneration with neurofilament inclusion bodies: Additional evidence for overlap between FTD and ALS. Neuropathol Appl Neuro-biol 2003;29:239-53
18. Yokota O, Tsuchiya K, Terada S, et al. Basophilic inclusion body disease and neuronal intermediate filament inclusion disease: A comparative clinicopathological study. Acta Neuropathol 2008;115:561-75
19. Bäumer D, Hilton D, Paine SM, et al. Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. Neurology 2010;75: 611-18
20. Vance C, Rogelj B, Hortobágyi T, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009;323:1208-11
21. Urwin H, Josephs KA, Rohrer JD, et al. FUS pathology defines the majority of tau-and TDP-43Ynegative frontotemporal lobar degeneration. Acta Neuropathol 2010;120:33-41
22. Schochet SS Jr, Earle KM. Pick's disease with compound intraneuronal inclusion bodies. Acta Neuropathol 1979;15:293-97
23. Mackenzie IR, Feldman H. Neurofilament inclusion body disease with early-onset frontotemporal dementia and primary lateral sclerosis. Clin Neuropathol 2004;23:183-93
24. Page T, Gitcho MA, Mosaheb S, et al. FUS immunogold labeling TEM analysis of the neuronal cytoplasmic inclusions of neuronal intermediate filament inclusion disease: A frontotemporal lobar degeneration with FUS proteinopathy. J Mol Neurosci 2011;45:409-21
25. Pikkarainen M, Martikainen P, Alafuzoff I. The effect of prolonged fixation time on immunohistochemical staining of common neurodegenerative disease markers. J Neuropathol Exp Neurol 2010;69:40-52